Alternatively, the induction of retinoic acid-inducible gene I (RIG-I) was demonstrated to reverse HLA-I suppression in patients with melanoma, suggesting that it could be targeted to overcome resistance to immune checkpoint blockades [68]. This evidence concerns the gene RIGI and melanoma.